Last reviewed · How we verify
NCT07048756: JM2019a
Psychotherapeutic Imagery Techniques
NA trial testing Imagery Rescripting in Fear of Failure in 220 participants. Completed in 1 June 2022.
1 June 2022
Quick facts
| Lead sponsor | University of Social Sciences and Humanities, Warsaw |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 220 |
| Start date | 1 June 2020 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 June 2022 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Imagery Rescripting
- Imagery Exposure
- Imagery Rescripting with Disruption of Reconsolidation
- Compassion-Focused Therapy Imagery Rescripting
Conditions studied
- Fear of Failure — all drugs for Fear of Failure →
Sponsor
University of Social Sciences and Humanities, Warsaw
Who can join
Adults 18 to 35, any sex, with Fear of Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled trial (RCT) examines the efficacy of Imagery Exposure (IE), Imagery Rescripting (ImRs), and Compassion-Focused Therapy (CFT) in individuals with a high fear of failure. Participants (N=220) were randomly assigned to IE, ImRs, ImRs with a 10-minute break (ImRs-DSR), or CFT-based Imagery Rescripting (CFT\_ImRs). Due to funding constraints, the CFT\_ImRs group included a reduced sample (N=40, targeting 30 completers). The two-week intervention consists of four structured imagery sessions. IE involves exposure to criticism-related memories without modification. In the ImRs group memory reactivation to criticism-related memories is followed by positive reappraisal. ImRs-DSR introduces a 10-minute delay before reappraisal to enhance memory updating. CFT\_ImRs incorporates Compassion-Focused Therapy (CFT) principles into reappraisal, emphasizing self-compassion. Primary outcomes include skin conductance level (SCL) and subjective emotional responses to criticism-related (and control) memories, changes in fear of failure and dysfunctional beliefs. All these variables are assessed pre-treatment, post-treatment, and at 3- and 6-month follow-ups. Results will be analyzed separately for: IE vs. ImRs (rescripting vs. exposure and physiological predictors), ImRs vs. ImRs-DSR (memory reconsolidation effects), IE vs. CFT\_ImRs (CFT vs. exposure efficacy).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Imagine yourself as a little girl…-efficacy and psychophysiology of imagery techniques targeting adverse autobiographical childhood experiences- multi-arm randomised controlled trial.
Bączek J, Karkosz S, Pietruch M, Szymański R, et al · · 2025 · PMID 41625469 · DOI 10.3389/fpsyg.2025.1710963
Verify or expand the search:
- PubMed search for NCT07048756
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Imagery Rescripting
Trials testing the same drug.
- NCT07362511 — Imagery Rescripting in Primary Care · NA · recruiting
- NCT05976945 — Imagery Rescripting as Treatment for Depression · NA · recruiting
- NCT07196085 — Neural Mechanisms and Efficacy of Imagery Rescripting for Fear of Failure · NA · completed
- NCT03607630 — Can Imagination Change Upsetting Memories of Trauma? · Phase 1, PHASE2 · unknown
Other recruiting trials for Fear of Failure
Currently open trials in the same condition.
- NCT07189715 — Optimization of Imagery Rescripting Research Using Generative Artificial Intelligence · NA · recruiting
Other University of Social Sciences and Humanities, Warsaw trials
Trials by the same sponsor.
- NCT06944990 — Meta Self-efficacy Internet Intervention to Improve Work Self-efficacy and Occupational Well-being in Young Employees · NA · not yet recruiting
- NCT07429617 — Effects of Darkness Retreat: a Pilot Study · NA · recruiting
- NCT07189715 — Optimization of Imagery Rescripting Research Using Generative Artificial Intelligence · NA · recruiting
- NCT06570694 — RCT Protocol for 'OverThinking': A Mobile EMI for Reducing Experiential Avoidance · NA · not yet recruiting
- NCT07405632 — The Impact of Supplementation With Hericium Erinaceus (Lion's Mane) Extract on Cognitive Functioning · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07048756 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Social Sciences and Humanities, Warsaw
- Last refreshed: 20 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07048756.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing